Abstract
Epithelial ovarian cancer (EOC) is the leading cause of death among all gynecological malignancies. Due to late presentation and diagnosis at an advanced stage, the mortality rate from ovarian cancer continues to be high. A lot of research for development of specific newer biomarkers for diagnosis and prognosis in EOC is occurring at a rapid pace. EOC is a highly heterogeneous disease characterized by many diverse histological and molecular subtypes [1]. Morphologically, these tumours are typed into serous, mucinous, endometrioid, clear cell, brenner and seromucinous types. These are then further divided into benign, borderline and malignant depending on the degree of cell proliferation, nuclear atypia and presence or absence of stromal invasion [2].
Highlights
A lot of research for development of specific newer biomarkers for diagnosis and prognosis in Epithelial ovarian cancer (EOC) is occurring at a rapid pace
EOC is a highly heterogeneous disease characterized by many diverse histological and molecular subtypes [1]. These tumours are typed into serous, mucinous, endometrioid, clear cell, brenner and seromucinous types
These are further divided into benign, borderline and malignant depending on the degree of cell proliferation, nuclear atypia and presence or absence of stromal invasion [2]
Summary
Epithelial ovarian cancer (EOC) is the leading cause of death among all gynecological malignancies. Due to late presentation and diagnosis at an advanced stage, the mortality rate from ovarian cancer continues to be high.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.